Journals / Türk Tıp Öğrencileri Araştırma Dergisi / 2026 / Cilt: 1 Sayı: 1

Pancreatic Cancer in an Elderly with Anti-PLA 2R Negative Membranous Nephropathy: Case Report

Anti-PLA 2R Negatif Membranöz Nefropatili İleri Yaş Hastada Pankreas Kanseri: Olgu Sunumu

Buket Kılıç(ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ)0000-0001-9981-0959
Burcu Özalp(ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ)0000-0002-4305-707X
Esra Can Önder(ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ)0000-0003-3540-3603
Hazal Tıraş(ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ)0000-0003-4559-6541
İlayda Aktacir(ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ)0000-0001-6302-3814
Sultan Özkurt(ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ)0000-0001-7552-2186
Pages
24–26
Publication Date
2019-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We are reporting a anti-PLA2R negative 65 years old female nephrotic sydrome patient who was diagnosed with pancreatic cancer while being scanned for maligencies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In Patients with newly diagnosed Membranous Nephropathy in advanced age with the absence of Anti-PLA2R antibodies in their circulation, must be evaluated thoroughly for occult malignancy.
📊
Key Findings & Data:In Patients with newly diagnosed Membranous Nephropathy in advanced age with the absence of Anti-PLA2R antibodies in their circulation, must be evaluated thoroughly for occult malignancy.
💡
Conclusion & Impact:We are reporting a anti-PLA2R negative 65 years old female nephrotic sydrome patient who was diagnosed with pancreatic cancer while being scanned for maligencies.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Anti-PLA2R antibodies · Anti-PLA2R antibodies

Abstract

In Patients with newly diagnosed Membranous Nephropathy in advanced age with the absence of Anti-PLA2R antibodies in their circulation, must be evaluated thoroughly for occult malignancy. We are reporting a anti-PLA2R negative 65 years old female nephrotic sydrome patient who was diagnosed with pancreatic cancer while being scanned for maligencies.

Özet

İdiyopatik Membranöz Nefropatide dolaşımda tesbit edilen anti-PLA2R otoantikorları saptanmayan yeni tanı almış Membranöz Nefropatili ileri yaş hastalarda okkult malignite ısrarla aranmalıdır. Biz Anti-PLA 2R negatif,65 yaşındaki nefrotik sendromlu bayan hastada malignite taramasıyla tesbit ettiğimiz pankreas kanseri vakasını bildiriyoruz

🔖

Cite This Article

Kılıç, B., Özalp, B., Önder, E. C., Tıraş, H., Aktacir, İ., Özkurt, S. (2019). Pancreatic Cancer in an Elderly with Anti-PLA 2R Negative Membranous Nephropathy: Case Report. Türk Tıp Öğrencileri Araştırma Dergisi, Cilt: 1 Sayı: 1, 24–26. https://ajindex.com/articles/1603448

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, Fervenza FC: Changing incidence of glomerular disease in OlmstedCounty, Minnesota: a 30-year renal biopsy study. Clin J Am SocNephrol 2006; 1: 483-487.
  2. Ponticelli C, Glassock RJ: Glomerular diseases: membranous nephropathy - a modern view. Clin J Am Soc Nephrol 2014;9:609-616.
  3. Lee JC, Yamauchi H, Hopper J Jr: Theassociation of cancer and the nephrotic syndrome. Ann Intern Med 1966;64:41-51.
  4. Leeaphorn N, Kue-A-Pai P, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014;40(1):29-35. doi: 10.1159/0003 64782.
  5. Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, Rossert J, GN-PROGRESS StudyGroup: Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. KidneyInt 2006;70:1510-1517.